| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 8, 2020Randomized Control Trial Results to be Presented at NANS Jan. 23-26 in Las Vegas; New, Proprietary Differential Target Multiplexed (DTM) Therapy Available on Medtronic Intellis Spinal Cord Stimulation Platform
DUBLIN, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced it has acquired Stimgenics, LLC, a privately-held company based in Bloomington, Illinois, that has pioneered a novel...
-
Dec 18, 2019Robotic Trajectory Guidance Platform Integrates Multiple Enabling Technologies to Support Complex Cranial Procedures
DUBLIN, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced that the U.S. Food and Drug Administration (FDA) recently cleared the Stealth Autoguide™ system, the first cranial...
-
Nov 4, 2019Action Seeks Relief to Prevent Further Infringement of Medtronic Patents
DUBLIN, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Medtronic, Inc. (NYSE:MDT) today filed a lawsuit against Axonics Modulation Technologies, Inc. (“Axonics”) alleging infringement of patents related to...
-
Oct 30, 2019System Offers at Home Therapy Management for DBS patients Using Patient-Friendly Consumer Technology
DUBLIN and SAN JOSE, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the U.S. launch of its advanced Patient Programmer technology for Deep Brain Stimulation...
-
Oct 7, 2019Smaller, Rechargeable Device Will Provide More Choices for Patients Suffering with Bladder and Bowel Control Issues
DUBLIN, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has filed a pre-market approval (PMA) supplement with the United States Food and Drug Administration (FDA) for...
-
Sep 26, 2019Medtronic Continues to Invest in Scientific Evidence for Expansion of Indications and Greater Clinical Understanding of Infuse™ Bone Graft
DUBLIN and CHICAGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced U.S. FDA approval of a prospective, randomized pivotal clinical trial for the use of Infuse™ Bone...
-
Sep 24, 2019Delivers the Industry’s Most Complete Portfolio of Implants, Biologics, Imaging, Navigation, Robotics, and Surface Technologies Designed to Transform Spine Outcomes
DUBLIN and CHICAGO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the launch of several new procedural solutions for spine surgery, further reinforcing the...
-
Sep 16, 2019Pathway Helps Physicians Better Identify Which Patients to Treat with Vertebral Augmentation, Which to Manage with Conservative Care
DUBLIN, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the National Osteoporosis Foundation (NOF) supports the VCF Care...
-
Jul 22, 2019Technology Has the Potential to Save Crucial Time and Increase Access to Lifesaving Stroke Treatments
DUBLIN and SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), a global leader in medical technology, and Viz.ai, the emerging leader in applied artificial intelligence (AI)...
-
Jun 27, 2019Acquisition Accelerates Medtronic’s Strategy to Transform Spinal Procedures and Improve Outcomes Through Complete Procedural Solutions
DUBLIN, June 27, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), a global leader in medical technology, today announced it has completed the acquisition of Titan Spine, a privately-held...